{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:35:46Z","timestamp":1789454146442,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T00:00:00Z","timestamp":1461024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jinf.2016.04.008","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T16:23:05Z","timestamp":1461342185000},"page":"45-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia"],"prefix":"10.1016","volume":"73","author":[{"given":"James D.","family":"Chalmers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahsan R.","family":"Akram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aran","family":"Singanayagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam T.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2016.04.008_bib1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/jac\/dkt477","article-title":"Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis","volume":"69","author":"Slimings","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2016.04.008_bib2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2016.04.008_bib3","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/cid\/cis614","article-title":"Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England","volume":"55","author":"Wilcox","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.04.008_bib4","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1056\/NEJMc1505190","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Banaei","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2016.04.008_bib5","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1473-3099(13)70200-7","article-title":"Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C. difficile infection","volume":"13","author":"Planche","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2016.04.008_bib6","unstructured":"Public Health England. Clostridium difficile: guidance, data and analysis. Annual counts and rates of C. difficile infections by acute trust and clinical commissioning group (CCG) in patients aged 2 years and over. https:\/\/www.gov.uk\/government\/statistics\/clostridium-difficile-infection-annual-data [accessed 25.06.15]."},{"key":"10.1016\/j.jinf.2016.04.008_bib7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/qjmed\/hcp027","article-title":"Severity assessment in community-acquired pneumonia: a review","volume":"102","author":"Singayagam","year":"2009","journal-title":"QJM"},{"key":"10.1016\/j.jinf.2016.04.008_bib8","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/jac\/dkq038","article-title":"Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic","volume":"65","author":"Chalmers","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2016.04.008_bib9","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/bmj.311.7016.1345","article-title":"Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime","volume":"311","author":"Impallomeni","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.jinf.2016.04.008_bib10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/thorax.55.8.633","article-title":"Respiratory antibiotic use and Clostridium difficile infection: is it the drugs or is it the doctors?","volume":"55","author":"Wilcox","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.jinf.2016.04.008_bib11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3201\/eid1405.071011","article-title":"Increasing hospital admissions for pneumonia, England","volume":"14","author":"Trotter","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jinf.2016.04.008_bib12","unstructured":"Health Protection Agency. Clostridium difficile infection: How to deal with the problem. https:\/\/www.gov.uk\/government\/publications\/clostridium-difficile-infection-how-to-deal-with-the-problem [accessed 25.06.15]."},{"key":"10.1016\/j.jinf.2016.04.008_bib13","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.mayocp.2012.07.016","article-title":"Clostridium difficile infection: new insights into management","volume":"87","author":"Khanna","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jinf.2016.04.008_bib14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12879-015-0925-9","article-title":"Impact of Clostridium difficile infection among pneumonia and urinary tract infection hospitalizations: an analysis of the Nationwide Inpatient Sample","volume":"15","author":"Becerra","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2016.04.008_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/cid\/cir274","article-title":"Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study","volume":"53","author":"Chalmers","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.04.008_bib16","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/jac\/dkq426","article-title":"Safety and efficacy of CURB65-guided antibiotic therapy in community-acquired pneumonia","volume":"66","author":"Chalmers","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2016.04.008_bib17","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1183\/09031936.00172910","article-title":"Physician judgement is a crucial adjunct to pneumonia severity scores in low-risk patients","volume":"38","author":"Choudhury","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2016.04.008_bib18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"American Thoracic Society\/Infectious Diseases Society of America","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2016.04.008_bib19","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A\u00a0simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jinf.2016.04.008_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revisited: the difference between two estimates","volume":"326","author":"Altman","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jinf.2016.04.008_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/thx.2007.095216","article-title":"Local guidelines for management of adult community acquired pneumonia: a survey of UK hospitals","volume":"64","author":"Barker","year":"2009","journal-title":"Thorax"},{"issue":"Suppl. 3","key":"10.1016\/j.jinf.2016.04.008_bib22","first-page":"iii1","article-title":"BTS guidelines for the management of community acquired pneumonia in adults: update 2009","volume":"64","author":"Lim","year":"2009","journal-title":"Thorax"},{"issue":"Suppl. 2","key":"10.1016\/j.jinf.2016.04.008_bib23","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.04.008_bib24","unstructured":"British Thoracic Society. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults: 2004 Update. https:\/\/www.brit-thoracic.org.uk\/document-library\/clinical-information\/pneumonia\/adult-pneumonia\/adult-cap-guideline-2001\/guidelines-for-the-management-of-community-acquired-pneumonia-in-adults-2004-update\/ [accessed 25.06.15]."},{"key":"10.1016\/j.jinf.2016.04.008_bib25","unstructured":"British Thoracic Society. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults: 2009 Update. https:\/\/www.brit-thoracic.org.uk\/document-library\/clinical-information\/pneumonia\/adult-pneumonia\/bts-guidelines-for-the-management-of-community-acquired-pneumonia-in-adults-2009-update\/ [accessed 26.06.15]."},{"key":"10.1016\/j.jinf.2016.04.008_bib26","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/jac\/dku515","article-title":"Antibiotic policies in acute English NHS trusts: implementation of \u2018Start Smart-Then Focus\u2019 and relationship with Clostridium difficile infection rates","volume":"70","author":"Llewelyn","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2016.04.008_bib27","unstructured":"Health Protection Scotland. The Annual Surveillance of Healthcare Associated Infection Report January \u2013 December 2009. http:\/\/www.documents.hps.scot.nhs.uk\/hai\/annual-report\/annual-surveillance-hai-report-2009.pdf [accessed 25.06.15]."},{"key":"10.1016\/j.jinf.2016.04.008_bib28","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1086\/605322","article-title":"Hand hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile","volume":"30","author":"Oughton","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jinf.2016.04.008_bib29","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/jamainternmed.2014.8273","article-title":"Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection","volume":"175","author":"Brown","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jinf.2016.04.008_bib30","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/jac\/dkg254","article-title":"Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review","volume":"51","author":"Thomas","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2016.04.008_bib31","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1093\/jac\/dkq329","article-title":"Impact of different empirical antibiotic treatment regimens for community-acquired pneumonia on the emergence of Clostridium difficile","volume":"65","author":"Bruns","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2016.04.008_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3201\/eid1202.050145","article-title":"Systematic review of antimicrobial drug prescribing in hospitals","volume":"12","author":"Davey","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jinf.2016.04.008_bib33","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/496986","article-title":"Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec","volume":"41","author":"Pepin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.04.008_bib34","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/jac\/dkt129","article-title":"Community-associated Clostridium difficile infection and antibiotics: a meta-analysis","volume":"68","author":"Deshpande","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2016.04.008_bib35","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMoa1406330","article-title":"Antibiotic treatment strategies for community-acquired pneumonia in adults","volume":"372","author":"Postma","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2016.04.008_bib36","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1111\/j.1469-0691.2011.03542.x","article-title":"Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia\u2013a propensity-adjusted analysis","volume":"17","author":"Choudhury","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2016.04.008_bib37","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/bmj.332.7554.1355","article-title":"Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study","volume":"332","author":"el Moussaoui","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jinf.2016.04.008_bib38","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1378\/chest.10-2895","article-title":"Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia","volume":"140","author":"Aliberti","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2016.04.008_bib39","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/jac\/dkt362","article-title":"A multidisciplinary intervention to reduce antibiotic duration in lower respiratory tract infections","volume":"69","author":"Murray","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2016.04.008_bib40","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/1469-0691.12173","article-title":"An evaluation of clinical stability criteria to predict hospital course in community-acquired pneumonia","volume":"19","author":"Akram","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2016.04.008_bib41","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1128\/JCM.01082-09","article-title":"Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods","volume":"47","author":"Eastwood","year":"2009","journal-title":"J Clin Microbiol"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445316300354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445316300354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:23:21Z","timestamp":1759008201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445316300354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0163445316300354"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2016.04.008","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2016.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}